FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020990138> ?p ?o ?g. }

• W2020990138 endingPage "752" @default.
• W2020990138 startingPage "744" @default.
• W2020990138 abstract "BackgroundWe investigated the effect of having clinic and/or ambulatory blood pressures (BPs) not at goal on cardiorenal risk in patients with non−dialysis-dependent chronic kidney disease (CKD).Study DesignMulticenter prospective study.Setting & Participants489 consecutive hypertensive patients with CKD (stages 1-5) with concomitant assessment of ambulatory and clinic BPs followed up in tertiary nephrology clinics.PredictorsAchievement of goal for ambulatory (day- and night-time BPs < 135/85 and <120/70 mm Hg, respectively) and clinic (<140/90 mm Hg) BPs was used to create 4 BP groups: clinic and ambulatory BPs at goal (group 1), clinic BP above goal and ambulatory BP at goal (group 2), clinic BP at goal and ambulatory BP above goal (group 3), and clinic and ambulatory BPs above goal (group 4).OutcomesComposite cardiovascular event outcome (fatal and nonfatal myocardial infarction, congestive heart failure, stroke, revascularization, peripheral vascular disease, and nontraumatic amputation) and a composite renal outcome (maintenance dialysis therapy or death).MeasurementsClinic and 24-hour ambulatory BPs.ResultsMean age was 64.4 ± 14.2 (SD) years; 41% were women, and diabetes and previous cardiovascular disease were present in 36% and 30%, respectively. Groups 1-4 contained 16.8%, 22.1%, 14.5%, and 46.6%, respectively, of the overall number of participants. Median follow-up was 5.2 years. Compared to group 1, the adjusted risk of the composite cardiovascular outcome was higher in groups 3 (HR, 3.17; 95% CI, 1.50-6.69) and 4 (HR, 2.83; 95% CI, 1.50-5.34), but not in group 2 (HR, 1.55; 95% CI, 0.75-3.19). Similarly, the risk of the composite renal outcome was higher in groups 3 (HR, 3.59; 95% CI, 2.05-6.27) and 4 (HR, 2.96; 95% CI, 1.83-4.78), but not group 2 (HR, 1.24; 95% CI, 0.67-2.27). Sensitivity analyses confirmed that these results were independent from the thresholds used for defining groups.LimitationsOnly white patients were enrolled. Observational design does not allow for causality to be established.ConclusionsIn patients with treated CKD, clinic BP above goal and ambulatory BP at goal identify a low-risk condition, whereas clinic BP at goal and ambulatory BP above goal are associated with higher cardiorenal risk, similar to that observed in patients with both clinic and ambulatory BPs above goal. We investigated the effect of having clinic and/or ambulatory blood pressures (BPs) not at goal on cardiorenal risk in patients with non−dialysis-dependent chronic kidney disease (CKD). Multicenter prospective study. 489 consecutive hypertensive patients with CKD (stages 1-5) with concomitant assessment of ambulatory and clinic BPs followed up in tertiary nephrology clinics. Achievement of goal for ambulatory (day- and night-time BPs < 135/85 and <120/70 mm Hg, respectively) and clinic (<140/90 mm Hg) BPs was used to create 4 BP groups: clinic and ambulatory BPs at goal (group 1), clinic BP above goal and ambulatory BP at goal (group 2), clinic BP at goal and ambulatory BP above goal (group 3), and clinic and ambulatory BPs above goal (group 4). Composite cardiovascular event outcome (fatal and nonfatal myocardial infarction, congestive heart failure, stroke, revascularization, peripheral vascular disease, and nontraumatic amputation) and a composite renal outcome (maintenance dialysis therapy or death). Clinic and 24-hour ambulatory BPs. Mean age was 64.4 ± 14.2 (SD) years; 41% were women, and diabetes and previous cardiovascular disease were present in 36% and 30%, respectively. Groups 1-4 contained 16.8%, 22.1%, 14.5%, and 46.6%, respectively, of the overall number of participants. Median follow-up was 5.2 years. Compared to group 1, the adjusted risk of the composite cardiovascular outcome was higher in groups 3 (HR, 3.17; 95% CI, 1.50-6.69) and 4 (HR, 2.83; 95% CI, 1.50-5.34), but not in group 2 (HR, 1.55; 95% CI, 0.75-3.19). Similarly, the risk of the composite renal outcome was higher in groups 3 (HR, 3.59; 95% CI, 2.05-6.27) and 4 (HR, 2.96; 95% CI, 1.83-4.78), but not group 2 (HR, 1.24; 95% CI, 0.67-2.27). Sensitivity analyses confirmed that these results were independent from the thresholds used for defining groups. Only white patients were enrolled. Observational design does not allow for causality to be established. In patients with treated CKD, clinic BP above goal and ambulatory BP at goal identify a low-risk condition, whereas clinic BP at goal and ambulatory BP above goal are associated with higher cardiorenal risk, similar to that observed in patients with both clinic and ambulatory BPs above goal." @default.
• W2020990138 created "2016-06-24" @default.
• W2020990138 creator A5009196186 @default.
• W2020990138 creator A5010126422 @default.
• W2020990138 creator A5019096846 @default.
• W2020990138 creator A5029246220 @default.
• W2020990138 creator A5048229494 @default.
• W2020990138 creator A5051708137 @default.
• W2020990138 creator A5052007121 @default.
• W2020990138 creator A5062292415 @default.
• W2020990138 creator A5076687280 @default.
• W2020990138 creator A5080793108 @default.
• W2020990138 date "2014-11-01" @default.
• W2020990138 modified "2023-10-14" @default.
• W2020990138 title "Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study" @default.
• W2020990138 cites W1968570468 @default.
• W2020990138 cites W1980809339 @default.
• W2020990138 cites W1995112014 @default.
• W2020990138 cites W1995144335 @default.
• W2020990138 cites W1997120493 @default.
• W2020990138 cites W2009108351 @default.
• W2020990138 cites W2024956494 @default.
• W2020990138 cites W2038197016 @default.
• W2020990138 cites W2039485177 @default.
• W2020990138 cites W2048615123 @default.
• W2020990138 cites W2057847137 @default.
• W2020990138 cites W2073140442 @default.
• W2020990138 cites W2074780401 @default.
• W2020990138 cites W2088819196 @default.
• W2020990138 cites W2088993478 @default.
• W2020990138 cites W2092816382 @default.
• W2020990138 cites W2093071489 @default.
• W2020990138 cites W2098352519 @default.
• W2020990138 cites W2102476412 @default.
• W2020990138 cites W2110901105 @default.
• W2020990138 cites W2113304720 @default.
• W2020990138 cites W2119953883 @default.
• W2020990138 cites W2123295328 @default.
• W2020990138 cites W2124054070 @default.
• W2020990138 cites W2126125759 @default.
• W2020990138 cites W2135233767 @default.
• W2020990138 cites W2136840691 @default.
• W2020990138 cites W2143459257 @default.
• W2020990138 cites W2143678577 @default.
• W2020990138 cites W2149159105 @default.
• W2020990138 cites W2154088205 @default.
• W2020990138 cites W2154746519 @default.
• W2020990138 cites W2161131149 @default.
• W2020990138 cites W2324521349 @default.
• W2020990138 cites W4229507647 @default.
• W2020990138 doi "https://doi.org/10.1053/j.ajkd.2014.06.014" @default.
• W2020990138 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25082100" @default.
• W2020990138 hasPublicationYear "2014" @default.
• W2020990138 type Work @default.
• W2020990138 sameAs 2020990138 @default.
• W2020990138 citedByCount "94" @default.
• W2020990138 countsByYear W20209901382014 @default.
• W2020990138 countsByYear W20209901382015 @default.
• W2020990138 countsByYear W20209901382016 @default.
• W2020990138 countsByYear W20209901382017 @default.
• W2020990138 countsByYear W20209901382018 @default.
• W2020990138 countsByYear W20209901382019 @default.
• W2020990138 countsByYear W20209901382020 @default.
• W2020990138 countsByYear W20209901382021 @default.
• W2020990138 countsByYear W20209901382022 @default.
• W2020990138 countsByYear W20209901382023 @default.
• W2020990138 crossrefType "journal-article" @default.
• W2020990138 hasAuthorship W2020990138A5009196186 @default.
• W2020990138 hasAuthorship W2020990138A5010126422 @default.
• W2020990138 hasAuthorship W2020990138A5019096846 @default.
• W2020990138 hasAuthorship W2020990138A5029246220 @default.
• W2020990138 hasAuthorship W2020990138A5048229494 @default.
• W2020990138 hasAuthorship W2020990138A5051708137 @default.
• W2020990138 hasAuthorship W2020990138A5052007121 @default.
• W2020990138 hasAuthorship W2020990138A5062292415 @default.
• W2020990138 hasAuthorship W2020990138A5076687280 @default.
• W2020990138 hasAuthorship W2020990138A5080793108 @default.
• W2020990138 hasBestOaLocation W20209901381 @default.
• W2020990138 hasConcept C126322002 @default.
• W2020990138 hasConcept C127413603 @default.
• W2020990138 hasConcept C134018914 @default.
• W2020990138 hasConcept C149323552 @default.
• W2020990138 hasConcept C164705383 @default.
• W2020990138 hasConcept C188816634 @default.
• W2020990138 hasConcept C2778198053 @default.
• W2020990138 hasConcept C2778653478 @default.
• W2020990138 hasConcept C2779978075 @default.
• W2020990138 hasConcept C2780645631 @default.
• W2020990138 hasConcept C2909406889 @default.
• W2020990138 hasConcept C35785553 @default.
• W2020990138 hasConcept C500558357 @default.
• W2020990138 hasConcept C54847362 @default.
• W2020990138 hasConcept C555293320 @default.
• W2020990138 hasConcept C71924100 @default.
• W2020990138 hasConcept C72563966 @default.
• W2020990138 hasConcept C78519656 @default.
• W2020990138 hasConcept C84393581 @default.
• W2020990138 hasConceptScore W2020990138C126322002 @default.

• next